Apollomics Inc.

Science-driven approach powering a pipeline of next-generation, combination and pan-cancer therapies for patients globally

2009

YEAR FOUNDED

DATE FIRST INVESTED

Discovery and development of oncology therapies
Faculty of Medicine

Profile

Apollomics is an innovative biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer.